Merriman Curhan Ford initiates coverage on CytRx Corporation (Nasdaq: CYTR) with a Buy. Price target range of $1.60-2.40.

Merriman analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE